{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:49:30Z","timestamp":1791413370861,"version":"4.3.3"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T00:00:00Z","timestamp":1486684800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100006364","name":"Institut National Du Cancer","doi-asserted-by":"publisher","award":["INCa-DHOS-5697"],"award-info":[{"award-number":["INCa-DHOS-5697"]}],"id":[{"id":"10.13039\/501100006364","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eur J Nucl Med Mol Imaging"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1007\/s00259-017-3641-4","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T11:14:35Z","timestamp":1486725275000},"page":"1145-1154","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":82,"title":["Correlation between tumour characteristics, SUV measurements, metabolic tumour volume, TLG and textural features assessed with 18F-FDG PET in a large cohort of oestrogen receptor-positive breast cancer patients"],"prefix":"10.1007","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2346-0678","authenticated-orcid":false,"given":"Charles","family":"Lemarignier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laetitia","family":"Vercellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Espi\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal","family":"Merlet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Groheux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,10]]},"reference":[{"key":"3641_CR1","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"533","author":"CM Perou","year":"2000","unstructured":"Perou CM, Sorlie T, Eisen MB, Van De Rijn M, Jeffrey SS, Rees CA, et al. Molecular portraits of human breast tumours. Nature. 2000;533:747\u201352.","journal-title":"Nature"},{"key":"3641_CR2","unstructured":"NCCN. Clinical Pratice Guidelines on Oncology - Breast Cancer. 2015."},{"key":"3641_CR3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10549-011-1488-0","volume":"131","author":"EH Lips","year":"2012","unstructured":"Lips EH, Mulder L, de Ronde JJ, Mandjes IAM, Vincent A, Vrancken Peeters MTFD, et al. Neoadjuvant chemotherapy in ER+ HER2\u2212 breast cancer: response prediction based on immunohistochemical and molecular characteristics. Breast Cancer Res Treat. 2012;131:827\u201336.","journal-title":"Breast Cancer Res Treat"},{"key":"3641_CR4","doi-asserted-by":"crossref","unstructured":"Groheux D, Hindi\u00e9 E, Delord M, Giacchetti S, Hamy A, Bazelaire C De, et al. Prognostic Impact of 18 FDG-PET-CT Findings in Clinical Stage III and IIB Breast Cancer. J. Natl. Cancer Inst. 2012;1879\u201387.","DOI":"10.1093\/jnci\/djs451"},{"key":"3641_CR5","doi-asserted-by":"crossref","unstructured":"Groheux D, Cochet A, Humbert O, Alberini J-L, Hindi\u00e9 E, Mankoff D. 18F-FDG PET\/CT for Staging and Restaging of Breast Cancer. J. Nucl. Med. Off. Publ. Soc. Nucl. Med. 2016;57 Suppl 1:17S\u201326S.","DOI":"10.2967\/jnumed.115.157859"},{"key":"3641_CR6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1007\/s00259-013-2616-3","volume":"41","author":"O Humbert","year":"2014","unstructured":"Humbert O, Berriolo-Riedinger A, Cochet A, Gauthier M, Charon-Barra C, Guiu S, et al. Prognostic relevance at 5 years of the early monitoring of neoadjuvant chemotherapy using (18)F-FDG PET in luminal HER2-negative breast cancer. Eur J Nucl Med Mol Imaging. 2014;41:416\u201327.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3641_CR7","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s10549-015-3303-9","volume":"150","author":"K Aogi","year":"2015","unstructured":"Aogi K, Kadoya T, Sugawara Y, Kiyoto S, Shigematsu H, Masumoto N, et al. Utility of (18)F FDG-PET\/CT for predicting prognosis of luminal-type breast cancer. Breast Cancer Res Treat. 2015;150:209\u201317.","journal-title":"Breast Cancer Res Treat"},{"key":"3641_CR8","doi-asserted-by":"crossref","unstructured":"Groheux D, Sanna A, Majdoub M, Cremoux P de, Giacchetti S, Teixeira L, et al. Baseline Tumor 18F-FDG Uptake and Modifications After 2 Cycles of Neoadjuvant Chemotherapy Are Prognostic of Outcome in ER+\/HER2- Breast Cancer. J. Nucl. Med. 2015;56.","DOI":"10.2967\/jnumed.115.154138"},{"key":"3641_CR9","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1007\/s00259-010-1640-9","volume":"38","author":"D Groheux","year":"2011","unstructured":"Groheux D, Giacchetti S, Moretti J-L, Porcher R, Espi\u00e9 M, Lehmann-Che J, et al. Correlation of high 18F-FDG uptake to clinical, pathological and biological prognostic factors in breast cancer. Eur J Nucl Med Mol Imaging. 2011;38:426\u201335.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3641_CR10","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1002\/cncr.28020","volume":"119","author":"D Groheux","year":"2013","unstructured":"Groheux D, Hatt M, Hindi\u00e9 E, Giacchetti S, de Cremoux P, Lehmann-Che J, et al. Estrogen receptor-positive\/human epidermal growth factor receptor 2-negative breast tumors: early prediction of chemosensitivity with (18)F-fluorodeoxyglucose positron emission tomography\/computed tomography during neoadjuvant chemotherapy. Cancer. 2013;119:1960\u20138.","journal-title":"Cancer"},{"key":"3641_CR11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2967\/jnumed.112.108837","volume":"54","author":"M Hatt","year":"2013","unstructured":"Hatt M, Groheux D, Martineau A, Espi\u00e9 M, Hindi\u00e9 E, Giacchetti S, et al. Comparison between 18F-FDG PET image-derived indices for early prediction of response to neoadjuvant chemotherapy in breast cancer. J Nucl Med. 2013;54:341\u20139.","journal-title":"J Nucl Med"},{"key":"3641_CR12","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.110.082404","volume":"52","author":"F Tixier","year":"2011","unstructured":"Tixier F, Cheze Le Rest C, Hatt M, Albarghach N, Pradier O, Metges J-P, et al. Intratumor heterogeneity characterized by textural features on baseline 18F-FDG PET images predicts response to concomitant radiochemotherapy in esophageal cancer. J Nucl Med. 2011;52:369\u201378.","journal-title":"J Nucl Med"},{"key":"3641_CR13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1148\/radiol.2015141309","volume":"276","author":"GJR Cook","year":"2015","unstructured":"Cook GJR, O\u2019Brien ME, Siddique M, Chicklore S, Loi HY, Sharma B, et al. Non\u2013Small Cell Lung Cancer Treated with Erlotinib: Heterogeneity of 18F-FDG Uptake at PET\u2014Association with Treatment Response and Prognosis. Radiology. 2015;276:883\u201393.","journal-title":"Radiology"},{"key":"3641_CR14","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.2967\/jnumed.108.053397","volume":"49","author":"JF Eary","year":"2008","unstructured":"Eary JF, Sullivan FO, Sullivan JO, Conrad EU. Spatial Heterogeneity in Sarcoma 18 F-FDG Uptake as a Predictor of Patient Outcome. J Nucl Med. 2008;49:1973\u20139.","journal-title":"J Nucl Med"},{"key":"3641_CR15","doi-asserted-by":"crossref","first-page":"e94017","DOI":"10.1371\/journal.pone.0094017","volume":"9","author":"M Soussan","year":"2014","unstructured":"Soussan M, Orlhac F, Boubaya M, Zelek L, Ziol M, Eder V, et al. Relationship between tumor heterogeneity measured on FDG-PET\/CT and pathological prognostic factors in invasive breast cancer. PLoS One. 2014;9:e94017.","journal-title":"PLoS One"},{"key":"3641_CR16","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/1471-2407-14-585","volume":"14","author":"SH Son","year":"2014","unstructured":"Son SH, Kim D-H, Hong CM, Kim C-Y, Jeong SY, Lee S-W, et al. Prognostic implication of intratumoral metabolic heterogeneity in invasive ductal carcinoma of the breast. BMC Cancer. 2014;14:585.","journal-title":"BMC Cancer"},{"key":"3641_CR17","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1007\/s00259-015-3110-x","volume":"42","author":"D Groheux","year":"2015","unstructured":"Groheux D, Majdoub M, Tixier F, Le Rest CC, Martineau A, Merlet P, et al. Do clinical, histological or immunohistochemical primary tumour characteristics translate into different 18F-FDG PET\/CT volumetric and heterogeneity features in stage II\/III breast cancer? Eur J Nucl Med Mol Imaging. 2015;42:1682\u201391.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3641_CR18","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.2967\/jnumed.115.163469","volume":"56","author":"I Buvat","year":"2015","unstructured":"Buvat I, Orlhac F, Soussan M. Tumor Texture Analysis in PET: Where Do We Stand? J Nucl Med. 2015;56:1642\u20134.","journal-title":"J Nucl Med"},{"key":"3641_CR19","doi-asserted-by":"crossref","unstructured":"Hatt M, Tixier F, Pierce L, Kinahan PE, Le Rest CC, Visvikis D. Characterization of PET\/CT images using texture analysis: the past, the present\u2026 any future? Eur. J. Nucl. Med. Mol. Imaging. 2016;1\u201315.","DOI":"10.1007\/s00259-016-3427-0"},{"key":"3641_CR20","unstructured":"Bundschuh R a, Dinges J, Neumann L, Seyfried M, Zs\u00f3t\u00e9r N, Papp L, et al. Textural Parameters of Tumor Heterogeneity in 18F-FDG PET\/CT for Therapy Response Assessment and Prognosis in Patients with Locally Advanced Rectal Cancer. J. Nucl. Med. 2014;55:891\u20137."},{"key":"3641_CR21","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2967\/jnumed.113.129858","volume":"55","author":"F Orlhac","year":"2014","unstructured":"Orlhac F, Soussan M, Maisonobe J-A, Garcia CA, Vanderlinden B, Buvat I. Tumor texture analysis in 18F-FDG PET: relationships between texture parameters, histogram indices, standardized uptake values, metabolic volumes, and total lesion glycolysis. J Nucl Med. 2014;55:414\u201322.","journal-title":"J Nucl Med"},{"key":"3641_CR22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2967\/jnumed.114.144055","volume":"56","author":"M Hatt","year":"2015","unstructured":"Hatt M, Majdoub M, Valli\u00e8res M, Tixier F, Le Rest CC, Groheux D, et al. 18F-FDG PET uptake characterization through texture analysis: investigating the complementary nature of heterogeneity and functional tumor volume in a multi-cancer site patient cohort. J Nucl Med. 2015;56:38\u201344.","journal-title":"J Nucl Med"},{"key":"3641_CR23","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0167-8140(03)00270-6","volume":"69","author":"J-F Daisne","year":"2003","unstructured":"Daisne J-F, Sibomana M, Bol A, Doumont T, Lonneux M, Gr\u00e9goire V. Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms. Radiother Oncol. 2003;69:247\u201350.","journal-title":"Radiother Oncol"},{"key":"3641_CR24","doi-asserted-by":"crossref","first-page":"6901","DOI":"10.1088\/0031-9155\/54\/22\/010","volume":"54","author":"S Vauclin","year":"2009","unstructured":"Vauclin S, Doyeux K, Hapdey S, Vera P. Development of a generic thresholding algorithm for the delineation of 18 FDG-PET-positive tissue: application to the comparison of three thresholding. Phys Med Biol. 2009;54:6901\u201316.","journal-title":"Phys Med Biol"},{"key":"3641_CR25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2967\/jnumed.108.057174","volume":"50","author":"RL Wahl","year":"2009","unstructured":"Wahl RL, Jacene H, Kasamon Y, Lodge MA. From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors Richard. J Nucl Med. 2009;50:1\u201350.","journal-title":"J Nucl Med"},{"key":"3641_CR26","unstructured":"Kurani AS, Xu D, Furst J, Raicu DS. Co-occurrence matrices for volumetric data. 7th IASTED Int. Conf. Comput. Graph. Imaging, Kauai. 2004."},{"key":"3641_CR27","doi-asserted-by":"crossref","first-page":"693","DOI":"10.2967\/jnumed.111.099127","volume":"53","author":"F Tixier","year":"2012","unstructured":"Tixier F, Hatt M, Le Rest CC, Le Pogam A, Corcos L, Visvikis D. Reproducibility of tumor uptake heterogeneity characterization through textural feature analysis in 18F-FDG PET. J Nucl Med. 2012;53:693\u2013700.","journal-title":"J Nucl Med"},{"key":"3641_CR28","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1007\/s00259-013-2486-8","volume":"40","author":"M Hatt","year":"2013","unstructured":"Hatt M, Tixier F, Cheze Le Rest C, Pradier O, Visvikis D. Robustness of intratumour 18F-FDG PET uptake heterogeneity quantification for therapy response prediction in oesophageal carcinoma. Eur J Nucl Med Mol Imaging. 2013;40:1662\u201371.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3641_CR29","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/S0140-6736(13)62422-8","volume":"384","author":"P Cortazar","year":"2014","unstructured":"Cortazar P, Zhang L, Untch M, Mehta K, Costantino JP, Wolmark N, et al. Pathological complete response and long-term clinical benefit in breast cancer : the CTNeoBC pooled analysis. Lancet. 2014;384:164\u201372.","journal-title":"Lancet"},{"key":"3641_CR30","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1109\/TSMC.1973.4309314","volume":"3","author":"RM Haralick","year":"1973","unstructured":"Haralick RM, Shanmugam K, Dinstein I. Textural Features for Image Classification. IEEE Trans Syst Man Cybern. 1973;3:610\u201321.","journal-title":"IEEE Trans Syst Man Cybern"},{"key":"3641_CR31","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1038\/ncomms5006","volume":"5","author":"HJWL Aerts","year":"2014","unstructured":"Aerts HJWL, Velazquez ER, Leijenaar RTH, Parmar C, Grossmann P, Cavalho S, et al. Decoding tumour phenotype by noninvasive imaging using a quantitative radiomics approach. Nat Commun. 2014;5:4006.","journal-title":"Nat Commun"},{"key":"3641_CR32","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s00259-016-3430-5","volume":"43","author":"D Groheux","year":"2016","unstructured":"Groheux D, Hindi\u00e9 E. Is 18FDG uptake useful to decide on chemotherapy in ER+\/HER2- breast cancer? Eur J Nucl Med Mol Imaging. 2016;43:1571\u20133.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3641_CR33","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2967\/jnumed.112.116715","volume":"55","author":"FJ Brooks","year":"2014","unstructured":"Brooks FJ, Grigsby PW. The effect of small tumor volumes on studies of intratumoral heterogeneity of tracer uptake. J Nucl Med. 2014;55:37\u201342.","journal-title":"J Nucl Med"},{"key":"3641_CR34","doi-asserted-by":"crossref","unstructured":"Orlhac F, Th\u00e9z\u00e9 B, Soussan M, Boisgard R, Buvat I. Multi-scale texture analysis: from 18F-FDG PET images to pathological slides. J. Nucl. Med. 2016","DOI":"10.2967\/jnumed.116.173708"},{"key":"3641_CR35","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1007\/s00259-010-1423-3","volume":"37","author":"H Zaidi","year":"2010","unstructured":"Zaidi H, El Naqa I. PET-guided delineation of radiation therapy treatment volumes: a survey of image segmentation techniques. Eur J Nucl Med Mol Imaging. 2010;37:2165\u201387.","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3641_CR36","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1200\/JCO.2007.15.4385","volume":"26","author":"LK Dunnwald","year":"2008","unstructured":"Dunnwald LK, Gralow JR, Ellis GK, Livingston RB, Linden HM, Specht JM, et al. Tumor metabolism and blood flow changes by positron emission tomography: relation to survival in patients treated with neoadjuvant chemotherapy for locally advanced breast cancer. J Clin Oncol Off J Am Soc Clin Oncol. 2008;26:4449\u201357.","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"key":"3641_CR37","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2967\/jnumed.115.166918","volume":"57","author":"F Tixier","year":"2016","unstructured":"Tixier F, Vriens D, Cheze- Le Rest C, Hatt M, Disselhorst JA, Oyen WJG, et al. Comparison of tumor uptake heterogeneity characterization between static and parametric 18F-FDG PET images in Non-Small Cell Lung Cancer. J Nucl Med. 2016;57:1033\u20139.","journal-title":"J Nucl Med"}],"container-title":["European Journal of Nuclear Medicine and Molecular Imaging"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00259-017-3641-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00259-017-3641-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,18]],"date-time":"2019-09-18T11:02:36Z","timestamp":1568804556000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00259-017-3641-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,10]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["3641"],"URL":"https:\/\/doi.org\/10.1007\/s00259-017-3641-4","relation":{},"ISSN":["1619-7070","1619-7089"],"issn-type":[{"value":"1619-7070","type":"print"},{"value":"1619-7089","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,10]]}}}